Medicare Enrolled

Dr. Adolfo Anchondo, M.D.

Pulmonary Disease · El Paso, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
4305 N MESA ST STE A, El Paso, TX 79902
9155322477
In practice since 2005 (20 years)
NPI: 1063410777 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Anchondo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Anchondo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Anchondo

Dr. Adolfo Anchondo is a pulmonary disease in El Paso, TX, with 20 years in practice. Based on federal Medicare data, Dr. Anchondo performed 4,205 Medicare services across 1,257 unique beneficiaries.

Between the years covered by Open Payments, Dr. Anchondo received a total of $10,243 from 39 pharmaceutical and/or device companies across 508 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Anchondo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 6% volume in TX$ $10,243 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,205
Medicare services
Top 6% in TX for pulmonary disease
1,257
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~210 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg2,000$1$2
Office visit, established patient (30-39 min)586$91$304
Critical care, first 30-74 min467$163$519
Hospital follow-up visit, moderate complexity208$59$189
Test to measure expiratory airflow and volume changes before and after medication administration129$28$89
Test to examine how well the lungs exchange gases126$41$132
Test to determine lung volumes using sensors121$40$127
Drug injection, under skin or into muscle112$11$34
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle101$53$168
Test for exercise-induced lung stress73$25$81
New patient office visit (45-59 min)57$121$395
Chest X-ray, 2 views51$24$80
Hospital follow-up visit, high complexity44$90$284
Initial hospital admission, moderate complexity43$96$310
Injection, methylprednisolone acetate, 80 mg32$9$80
CT scan of chest, without contrast24$83$328
Test to measure lung airway sensitivity20$46$144
Echocardiogram, transthoracic11$150$466
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
6.4% medium
93.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$10,243
Total received (2018-2024)
Avg $1,463/year across 7 years
Top 20% in TX for pulmonary disease
39
Companies
508
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,243 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,322
2023
$3,222
2022
$1,285
2021
$698
2020
$873
2019
$1,465
2018
$1,379

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$2,846
Pulmonx Corporation
$1,791
GlaxoSmithKline, LLC.
$1,365
Mylan Specialty L.P.
$525
Novartis Pharmaceuticals Corporation
$510
Boehringer Ingelheim Pharmaceuticals, Inc.
$485
GENZYME CORPORATION
$385
Sunovion Pharmaceuticals Inc.
$340
Grifols USA, LLC
$311
Regeneron Healthcare Solutions, Inc.
$265
Actelion Pharmaceuticals US, Inc.
$208
United Therapeutics Corporation
$177
Insmed, Inc.
$116
Ethicon Inc.
$106
Genentech USA, Inc.
$79
Circassia Pharmaceuticals Inc
$72
Amgen Inc.
$67
Takeda Pharmaceuticals U.S.A., Inc.
$66
Philips Electronics North America Corporation
$59
Baxter Healthcare
$52
Bard Access Systems, Inc.
$45
Inogen, Inc.
$42
Gilead Sciences, Inc.
$40
PFIZER INC.
$31
Mallinckrodt Enterprises LLC
$27
Biogen, Inc.
$25
Ceribell, Inc.
$24
E.R. Squibb & Sons, L.L.C.
$20
Bayer HealthCare Pharmaceuticals Inc.
$17
Eurofins Viracor, LLC
$17
Horizon Therapeutics plc
$17
ABBVIE INC.
$16
SANOFI-AVENTIS U.S. LLC
$16
BOSTON SCIENTIFIC CORPORATION
$16
Phadia US Inc.
$16
Philips North America LLC
$13
EKOS Corporation
$12
Merck Sharp & Dohme Corporation
$12
Strongbridge US INC.
$11
Top 3 companies account for 58.6% of total payments
Associated products mentioned in payments ›
(AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · AVAGE · Arikayce · BREO · BREZTRI · BYETTA · CHANTIX · CHARTIS CATHETER · Ceribell Rapid Response EEG · DUAKLIR PRESSAIR · DUPIXENT · Dymista · EKOSONIC · ELIQUIS · EXALT · Esbriet · FASENRA · GLASSIA · Hillrom - Vest System Model 105 Home Care · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · ImmunoCAP · KEVEYIS · LONHALA MAGNAIR · Monarch Platform · NIOX VERO · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · POWERPICC SOLO · PREVNAR 20 · Prolastin-C Liquid · RAYOS · Respiratoriy Care Undiv · SPINRAZA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · UPTRAVI · UTIBRON · Utibron · Vitrakvi · Wellcentive Undiv · XOLAIR · Xolair · YUPELRI · Yupelri · ZEPHYR ENDOBRONCHIAL VALVE · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $244 per 100 Medicare services performed
Looking for a pulmonary disease in El Paso?
Compare pulmonary diseases in the El Paso area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
13
Per 100K population
1.5
County median income
$58,859
Nearest hospital
THE HOSPITALS OF PROVIDENCE - MEMORIAL CAMPUS
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Anchondo is a clinical cardiology specialist, with above-average Medicare volume (top 6% in TX), and high industry engagement (low-engagement, top 20%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Anchondo experienced with methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg?
Based on Medicare claims data, Dr. Anchondo performed 2,000 methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Anchondo receive payments from pharmaceutical companies?
Yes. Dr. Anchondo received a total of $10,243 from 39 companies across 508 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Anchondo's costs compare to other pulmonary diseases in El Paso?
Dr. Anchondo's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Anchondo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →